The global hernia mesh devices market was valued at USD 4.6 billion in 2022 and is expected to reach USD 6.5 billion by 2032, reflecting a Compound Annual Growth Rate (CAGR) of 3.4%. Inguinal hernias ...

Companies currently being sued for their hernia mesh products include: Atrium Covidien, which is owned by Medtronic C.R. Bard and Davol Inc., which are owned by Becton, Dickinson and Company (BD) ...

BD (NYSE: BDX) announced today that it received FDA 510(k) clearance for its Phasix ST umbilical hernia patch.

The traditional treatment for hernias has been open surgery with a large incision that allows the surgeon to push the hernia back in place, then sewing the defect in the abdominal ...

"The combination of the unique features of the Ventralex™ ST Hernia Patch with the bioabsorbable nature of Phasix™ Mesh is a wonderful fusion of technology." Composed of Poly-4-hydroxybutyrate ...

"The combination of the unique features of the Ventralex™ ST Hernia Patch with the bioabsorbable nature of Phasix™ Mesh is a wonderful fusion of technology." Composed of Poly-4-hydroxybutyrate (P4HB), ...

For example, in a study comparing suture repair of incisional hernia to mesh repair, it was found that "mesh repair results in a lower recurrence rate and less abdominal pain and does not result ...

It is modelled after the Ventralex ST Hernia Patch, a product with a global implantation record of more than two million. The patch is the newest addition to the company’s Phasix Mesh product line. It ...